SEC secures admission from Orthofix after repeat FCPA violations
In a rare move, the US Securities and Exchange Commission obtained an admission of wrongdoing from Orthofix, a medical device company, in a foreign bribery settlement that did not involve parallel criminal charges.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10